<- Go Home

Diaceutics PLC

Diaceutics PLC, a diagnostic commercialisation company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialisation platform for precision medicine that integrates multiple pipelines of diagnostic testing data from network of laboratories. It also provides DXRX data solutions, including DXRX Signal, which delivers an actionable alert of a testing behavior for making treatment decisions; DXRX Physician Mapping that examines physician testing behavior using patient level data to determine testing rates, methodology, and the physician to lab relationship; DXRX Lab Mapping that offers insights into labs currently testing patients diagnosed with a specific disease or biomarker; and DXRX Disease Testing Rate Tracker, which delivers biomarker testing rate reports. In addition, the company offers professional services, such as market landscape, implementation, and consulting services. It operates in North America, the United Kingdom, Europe, Asia, and internationally. Diaceutics PLC was incorporated in 2005 and is headquartered in Belfast, the United Kingdom.

Market Cap

GBP 106.1M

Volume

100.2K

Cash and Equivalents

GBP 12.7M

EBITDA

GBP 552.0K

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

GBP 28.3M

Profit Margin

87.91%

52 Week High

GBP 1.51

52 Week Low

GBP 1.06

Dividend

N/A

Price / Book Value

2.66

Price / Earnings

-62.13

Price / Tangible Book Value

4.34

Enterprise Value

GBP 94.4M

Enterprise Value / EBITDA

133.72

Operating Income

-GBP 2.5M

Return on Equity

4.22%

Return on Assets

-3.23

Cash and Short Term Investments

GBP 12.7M

Debt

GBP 1.1M

Equity

GBP 39.9M

Revenue

GBP 32.2M

Unlevered FCF

-GBP 2.3M

Sector

Life Sciences Tools and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches